138 related articles for article (PubMed ID: 24801906)
1. Prognostic value of CYP2W1 expression in patients with human hepatocellular carcinoma.
Zhang K; Jiang L; He R; Li BL; Jia Z; Huang RH; Mu Y
Tumour Biol; 2014 Aug; 35(8):7669-73. PubMed ID: 24801906
[TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.
Cui J; Yu Y; Lu GF; Liu C; Liu X; Xu YX; Zheng PY
Tumour Biol; 2013 Jun; 34(3):1913-8. PubMed ID: 23516026
[TBL] [Abstract][Full Text] [Related]
4. DLX4 as a prognostic marker for hepatocellular carcinoma.
Gao Y; Li Z; Guo X; Liu Y; Zhang K
Neoplasma; 2014; 61(3):318-23. PubMed ID: 24824934
[TBL] [Abstract][Full Text] [Related]
5. Expression of HSPA2 in human hepatocellular carcinoma and its clinical significance.
Fu Y; Zhao H; Li XS; Kang HR; Ma JX; Yao FF; Du N
Tumour Biol; 2014 Nov; 35(11):11283-7. PubMed ID: 25117073
[TBL] [Abstract][Full Text] [Related]
6. The impact of L-type amino acid transporter 1 (LAT1) in human hepatocellular carcinoma.
Li J; Qiang J; Chen SF; Wang X; Fu J; Chen Y
Tumour Biol; 2013 Oct; 34(5):2977-81. PubMed ID: 23696029
[TBL] [Abstract][Full Text] [Related]
7. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
Chen XQ; He JR; Wang HY
Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
[TBL] [Abstract][Full Text] [Related]
9. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
10. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.
Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY
Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of liver-type fatty acid-binding protein is associated with poor prognosis in hepatocellular carcinoma.
Wang B; Tao X; Huang CZ; Liu JF; Ye YB; Huang AM
Hepatogastroenterology; 2014; 61(133):1321-6. PubMed ID: 25436304
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Leucine Zipper Protein mRNA in Hepatocellular Carcinoma Associated With Poor Prognosis.
Li G; Yuan L; Liu D; Liu J
Technol Cancer Res Treat; 2016 Jun; 15(3):517-22. PubMed ID: 26031464
[TBL] [Abstract][Full Text] [Related]
13. High expression of N-acetyltransferase 10: a novel independent prognostic marker of worse outcome in patients with hepatocellular carcinoma.
Zhang X; Liu J; Yan S; Huang K; Bai Y; Zheng S
Int J Clin Exp Pathol; 2015; 8(11):14765-71. PubMed ID: 26823802
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma.
Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
Clin Transl Oncol; 2014 Jan; 16(1):57-63. PubMed ID: 23632812
[TBL] [Abstract][Full Text] [Related]
15. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of Rab27A/B correlates with clinical outcome in hepatocellular carcinoma.
Dong WW; Mou Q; Chen J; Cui JT; Li WM; Xiao WH
World J Gastroenterol; 2012 Apr; 18(15):1806-13. PubMed ID: 22553406
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma.
Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y
Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
19. High expression of myofibrillogenesis regulator-1 predicts poor prognosis for patients with hepatocellular carcinoma after curative hepatectomy.
Wang C; Xiang H; Si H; Guo D; Sun M
Int J Clin Exp Pathol; 2015; 8(11):14818-23. PubMed ID: 26823810
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid receptor-related receptor alpha (RORalpha) is a prognostic marker for hepatocellular carcinoma.
Fu RD; Qiu CH; Chen HA; Zhang ZG; Lu MQ
Tumour Biol; 2014 Aug; 35(8):7603-10. PubMed ID: 24798975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
